Studying the potential of upregulated PTGS2 and VEGF-C besides

Por um escritor misterioso

Last updated 31 janeiro 2025

Studying the potential of upregulated PTGS2 and VEGF-C besides

Mice carrying an epithelial deletion of the glucocorticoid receptor NR3C1 develop a higher tumor load in experimental colitis-associated cancer

Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia

Rabbit polyclonal antibody to NF-kB p65. (A256703)

Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia

COX-2 modulates mammary tumor progression in response to collagen density, Breast Cancer Research

Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia

Sinensetin Attenuated Macrophagic NLRP3 Inflammasomes Formation via SIRT1-NRF2 Signaling

The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia

Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia

Frontiers Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

IJMS, Free Full-Text

Genes, Free Full-Text

Recomendado para você